Uncategorized

UK Stocks That May Be Trading Below Estimated Value In June 2026

The United Kingdom’s stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines due to weak trade data from China, highlighting concerns about global economic recovery. In such an environment, identifying stocks that may be trading below their estimated value can provide opportunities for investors seeking to capitalize on potential market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom

Name

Current Price

Fair Value (Est)

Discount (Est)

Vulcan Two Group (AIM:VUL)

£2.65

£5.25

49.6%

Tristel (AIM:TSTL)

£3.825

£7.59

49.6%

RHI Magnesita (LSE:RHIM)

£29.70

£55.89

46.9%

Playtech (LSE:PTEC)

£3.458

£6.57

47.3%

Mitie Group (LSE:MTO)

£1.732

£3.40

49%

M&G (LSE:MNG)

£3.153

£6.03

47.7%

Man Group (LSE:EMG)

£2.92

£5.82

49.8%

Hostelworld Group (LSE:HSW)

£1.09

£2.17

49.7%

Fevertree Drinks (AIM:FEVR)

£7.515

£14.94

49.7%

BTG Consulting (AIM:BTG)

£1.235

£2.44

49.3%

Click here to see the full list of 54 stocks from our Undervalued UK Stocks Based On Cash Flows screener.

Let’s explore several standout options from the results in the screener.

Overview: Dr. Martens plc is involved in the design, development, procurement, marketing, sale, and distribution of footwear with a market cap of approximately £696.75 million.

Operations: The company’s revenue primarily comes from its footwear segment, which generated £764.90 million.

Estimated Discount To Fair Value: 16.8%

Dr. Martens is trading 16.8% below its estimated fair value and slightly undervalued based on discounted cash flow, with a trading price of £0.73 against a future cash flow value of £0.87. Despite slower revenue growth forecasts at 4.5% annually, earnings are expected to grow significantly at 29.5% per year, outpacing the UK market’s average growth rate of 11.5%. Recent earnings showed substantial improvement in net income from £4.5 million to £23.8 million year-over-year, though dividend coverage remains weak at 3.5%.

LSE:DOCS Discounted Cash Flow as at Jun 2026

Overview: Man Group Limited is a publicly owned investment manager with a market cap of £3.26 billion, focusing on providing a range of investment strategies and solutions.

Operations: The company’s revenue from its Investment Management Business segment amounts to $1.41 billion.

Estimated Discount To Fair Value: 49.8%

Man Group is trading at £2.92, significantly below its estimated future cash flow value of £5.82, indicating substantial undervaluation based on discounted cash flow analysis. While the dividend yield of 4.37% lacks robust coverage by earnings or free cash flows, earnings are projected to grow significantly at 26.54% annually, surpassing the UK market’s average growth rate of 11.5%. Recent expansion efforts in Abu Dhabi highlight strategic global positioning and potential for increased investor engagement in the Middle East region.

LSE:EMG Discounted Cash Flow as at Jun 2026
LSE:EMG Discounted Cash Flow as at Jun 2026

Overview: Norcros plc, with a market cap of £265.17 million, designs and supplies bathroom and kitchen products across the United Kingdom, Ireland, and South Africa.

Operations: The company generates £370.50 million in revenue from its Building Products segment.

Estimated Discount To Fair Value: 40.7%

Norcros is trading at £2.95, well below its estimated future cash flow value of £4.97, highlighting significant undervaluation. Earnings are expected to grow substantially at 22.2% per year, outpacing the UK market’s average growth rate of 11.5%. Despite a challenging market environment and an unstable dividend track record, recent guidance forecasts group revenue growth of approximately 10%, driven by strategic contributions from Fibo and market share gains.

LSE:NXR Discounted Cash Flow as at Jun 2026
LSE:NXR Discounted Cash Flow as at Jun 2026

Next Steps

Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include LSE:DOCS LSE:EMG and LSE:NXR.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Source link

Visited 1 times, 1 visit(s) today

Leave a Reply

Your email address will not be published. Required fields are marked *